P2471A randomised, placebo-controlled trial of the effects of IV serelaxin on myocardial blood flow and vascular function in patients with stable coronary artery disease (CAD)

Authors :: Aleksandra Radjenovic
M.E. Hinder
Sheraz A Nazir
B. Gugliotta
David Corcoran
Gerry P McCann
David E. Newby
Colin Berry
Scott Semple
Denise Yates
Ify R. Mordi
Iain B. Squire
Niko Tzemos
S. Machineni
S. Wilson
Source :: European Heart Journal. 38
Publication Year :: 2017
Publisher :: Oxford University Press (OUP), 2017.

Subjects :: medicine.medical_specialty
business.industry
Placebo-controlled study
CAD
Blood flow
medicine.disease
Coronary artery disease
Serelaxin
Internal medicine
Cardiology
Medicine
In patient
Cardiology and Cardiovascular Medicine
business
Vascular function

Tools